Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M310Revenue (TTM) $M7.1Net Margin (%)-276.0Altman Z-Score6.2
Enterprise Value $M291EPS (TTM) $-0.3Operating Margin %-1,083.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-540.2Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %32.4Quick Ratio4.2Cash flow > EarningsN
Price/Sales36.15-y EBITDA Growth Rate %28.0Current Ratio4.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-22.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-65.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M103ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with BTX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BTX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BROADWOOD PARTNERS LPDirector, 10% Owner 2016-06-21Buy2,732,636$2.3925.52view
BROADWOOD PARTNERS LPDirector, 10% Owner 2016-01-20Buy300,000$2.3527.66view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2016-01-20Sell300,000$2.3527.66view
FARRELL STEPHEN CDirector 2015-11-06Buy50,000$3.83-21.67view
Russell Angus C.Director 2015-11-06Buy50,000$3.83-21.67view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2015-11-06Sell100,000$3.83-21.67view
ANDREWS DEBORAH JDirector 2015-08-26Buy2,000$2.826.38view
Cartt Stephen LaHueDirector 2015-08-18Buy75,000$2.87.14view
Russell Angus C.Director 2014-12-12Sell0$07.14view
Cartt Stephen LaHueDirector 2014-11-04Sell0$07.14view

Quarterly/Annual Reports about BTX:

News about BTX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BTX, CWST, BKSC, STAG Jun 27 2011 
Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 

More From Other Websites
BIOTIME INC Financials Aug 18 2016
Asterias Biotherapeutics Reports Second Quarter Results and Highlights Progress of SCiSTAR Study... Aug 15 2016
ETF’s with exposure to BioTime, Inc. : August 15, 2016 Aug 15 2016
BioTime Announces Issuance of 31 New Patents to Strengthen its Patent Portfolio in Regenerative... Aug 15 2016
BioTime Announces Issuance of 31 New Patents to Strengthen its Patent Portfolio in Regenerative... Aug 15 2016
BioTime, Inc. :BTX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 Aug 12 2016
BioTime, Inc. Reports Second Quarter Results and Recent Corporate Accomplishments Aug 09 2016
BIOTIME INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 09 2016
BioTime, Inc. Reports Second Quarter Results and Recent Corporate Accomplishments Aug 09 2016
Q2 2016 BioTime Inc Earnings Release - After Market Close Aug 09 2016
BioTime, Inc. to Report Second Quarter Results on August 9, 2016 Jul 27 2016
BioTime, Inc. to Report Second Quarter Results on August 9, 2016 Jul 27 2016
ETF’s with exposure to BioTime, Inc. : July 21, 2016 Jul 21 2016
Corporate Document-Investor Presentation for BioTime, Inc. Jul 20 2016
ETF’s with exposure to BioTime, Inc. : July 7, 2016 Jul 07 2016
BIOTIME INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 05 2016
BioTime, Inc. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option Jul 05 2016
BioTime, Inc. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option Jul 05 2016
BioTime Presents Online Resource for Applying Artificial Intelligence to Stem Cell Biology at Mensa... Jun 29 2016
BioTime Presents Online Resource for Applying Artificial Intelligence to Stem Cell Biology at Mensa... Jun 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)